
An Automated Assist in Revenue Cycle Management
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Experts Nathan Buchbinder and Julianna Ianni discuss digital pathology and AI trends in 2024—and what the next year may hold
The potential occupational safety pros and cons of artificial intelligence implementation into the clinical lab
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding